NCCN临床实践指南：生存指南（2025.V1）
指南制定者：美国国家综合癌症网络
出处：NCCN官网
发布时间：2025-04-08
1.指南来源（Guide Source）:
NCCN临床实践指南:生存指南 V1.2025.发布已获NCCN肿瘤学临床实践指南(NCCN指南®)许可。©2025美国国家综合癌症网络公司.保留所有权利。未经NCCN明确的书面许可，不得出于任何目的以任何形式复制NCCN指南®和文中的插图。要查看NCCN指南的最新完整版本，请访问NCCN.org。NCCN指南是一项持续进行的工作，可能会随着新的重要数据的出现而不断完善。
2.免责声明（Disclaimers）：
NCCN对其内容、使用或应用不做任何形式的担保，并否认以任何方式对其应用或使用承担任何责任。
在下载本篇指南前，请先您详细阅读并同意以下协议：
NCCN内容不得用于商业目的，以及NCCN作为NCCN内容的许可方，不作任何陈述或保证，并明确否认NCCN指南适用于任何特定患者的护理或治疗，任何医院、寻求使用《NCCN指南》治疗患者的临床医生或其他医疗服务提供者(“提供者”)应根据特定患者护理或治疗的具体临床情况做出独立的医疗判断，NCCN不建议、推荐或认可任何提供者(无论是否与被许可方相关)进行任何有偿或无偿的医疗治疗、咨询或服务，也不应因被许可方建议、推荐或认可任何此类提供者的作为或不作为而直接或间接承担责任。详见《NCCN最终用户许可协议》
3.专家名单（Staff）：
*Tara Sanft, MD/Chair † Þ Yale Cancer Center/ Smilow Cancer Hospital
Amye Tevaarwerk, MD ‡/ Immediate Past Vice-Chair University of Wisconsin Carbone Cancer Center
Shannon Ansbaugh ¥ Patient Advocate
Saro Armenian, DO, MPH € City of Hope National Medical Center
K. Scott Baker, MD, MS € ξ Fred Hutchinson Cancer Research Center/ Seattle Cancer Care Alliance
Gregory Broderick, MD w Mayo Clinic Cancer Center
Andrew Day, MD, MPH ¶ UT Southwestern Simmons Comprehensive Cancer Center
Wendy Demark-Wahnefried, PhD, RD ≅ O’Neal Comprehensive Cancer Center at UAB Kristin Dickinson, PhD, RN § Fred & Pamela Buffett Cancer Center
Nathan Paul Fairman, MD, MPH £ UC Davis Comprehensive Cancer Center
Debra L. Friedman, MD, MS € ‡ † Vanderbilt-Ingram Cancer Center
Mindy Goldman, MD Ω UCSF Helen Diller Family Comprehensive Cancer Center
Norah Lynn Henry, MD, PhD † University of Michigan Rogel Cancer Center
Christine Hill-Kayser, MD € ‡ Abramson Cancer Center at the University of Pennsylvania
Melissa Hudson, MD € ‡ † St. Jude Children's Research Hospital/The University of Tennessee Health Science Center
Nazanin Khakpour, MD ¶ Moffitt Cancer Center
Divya Koura, MD ‡ ξ UC San Diego Moores Cancer Center
Allison L. McDonough, MD Þ Massachusetts General Hospital Cancer Center
Michelle Melisko, MD † £ UCSF Helen Diller Family Comprehensive Cancer Center
Kathi Mooney, RN, PhD # † Huntsman Cancer Institute at the University of Utah
Halle C. F. Moore, MD † Case Comprehensive Cancer Center/University Hospitals Seidman Cancer Center and Cleveland Clinic Taussig Cancer Institute
Natalie Moryl, MD Þ £ Memorial Sloan Kettering Cancer Center
Tracey O’Connor, MD † Roswell Park Comprehensive Cancer Center
Linda Overholser, MD, MPH Þ University of Colorado Cancer Center
Electra D. Paskett, PhD ɛ The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute
Chirayu Patel, MD, MPH § Massachusetts General Hospital Cancer Center
Lindsay Peterson, MD, MSCR † Siteman Cancer Center at Barnes- Jewish Hospital and Washington University School of Medicine
William Pirl, MD, MPH q Dana-Farber/Brigham and Women's Cancer Center
Andrea Porpiglia, MD, MSc ¶ Fox Chase Cancer Center
M. Alma Rodriguez, MD ‡ † Þ The University of Texas MD Anderson Cancer Center
Kathryn J. Ruddy, MD, MPH ‡ † Mayo Clinic Cancer Center
Lidia Schapira, MD † Stanford Cancer Institute
Lillie Shockney, RN, MAS # ¶ The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Sophia Smith, PhD, MSW £ Duke Cancer Institute
Karen L. Syrjala, PhD q £ Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance
Eric Yang, MD l UCLA Jonsson Comprehensive Cancer Center
Phyllis Zee, MD, PhD ɛ ψ Robert H. Lurie Comprehensive Cancer Center of Northwestern University
NCCN Deborah Freedman-Cass, PhD Nicole McMillian, MS
4.临床试验（Clinical Trials）：
NCCN认为任何癌症患者都可以在临床试验中得到最佳治疗，因此特别鼓励患者参与临床试验。 寻找NCCN成员组：https://www.nccn.org/home/member-institutions
5.NCCN对证据和共识分类（ NCCN Categories of Evidence and Consensus）：
推荐均为2A类，除非另有说明，请参见下表：
|
|
NCCN 对证据和共识的分类 |
|
1类 |
基于高水平证据，NCCN一致认为此项治疗合理 |
|
2A类 |
基于低水平证据，NCCN一致认为此项治疗合理 |
| 点赞 收藏   会务通参会助手  会务通订阅号  会务通服务号      |